Malvern, PA & Del Mar, CA - March 27th, 2026 - Cor Medical Ventures and Runway Healthcare have entered into a formal collaboration to accelerate the development and commercialization of early-stage medical device innovations. The two venture studios will work together to share deal flow and co-invest in promising opportunities across musculoskeletal, cardiovascular, and neurosurgical markets.
The partnership combines complementary capabilities to support companies from concept through exit. Cor Medical Ventures contributes deep in-house expertise in product development, regulatory strategy, quality systems, and operational execution. Runway Healthcare provides capital, strategic growth support, and an established network of acquiring strategics to guide portfolio companies toward successful exits.
Together, the organizations create an integrated platform that supports the entire development lifecycle—from early concept formation and clinical strategy through FDA clearance and acquisition—under a single, aligned partnership.
Collectively, Cor Medical Ventures and Runway Healthcare bring a broad network of clinicians, operators, investors, and strategic partners, along with decades of combined experience launching and scaling medical technologies. Their shared track record across device development, regulatory approvals, and successful exits positions the partnership to identify high-potential innovations and efficiently bring them to market.
While early-stage medtech has never lacked for ideas, it has often lacked the infrastructure required to systematically build and scale them. This collaboration was formed to provide that infrastructure—pairing capital, expertise, and execution capabilities to translate promising concepts into impactful medical technologies.
For more information visit: